D-dimer test for pneumonia severity and survival
Part of Blood & lymphatic, Lungs & breathing clinical trials.
This study looks at a blood test called D-dimer to see if it can predict how severe your pneumonia will be and how well you will recover. It helps doctors understand inflammation and survival in adults with community-acquired pneumonia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with community-acquired pneumonia (a lung infection you caught outside of a hospital).
- You do not have a bleeding or clotting disorder.
- You do not have cancer or other serious long-term illnesses.
- You do not have any signs or symptoms of COVID-19 pneumonia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how doctors decide to test for pulmonary embolism (a blood clot in the lungs) in the emergency department. It helps understand what factors lead to testing, which could improve care for future patients.
This study looks at how doctors test for superficial vein thrombosis (a blood clot in a vein near the skin) in the emergency department. It aims to improve detection and care for patients with this condition.
This study looks at whether a simple blood test can help diagnose and predict the outcome of lung infections that happen while a patient is on a breathing machine. It compares a newer blood marker (heparin binding protein) with standard platelet tests to see which is more accurate.
This study is testing a new D-dimer blood test (AQT90 FLEX) to see how well it detects blood clots in people who have symptoms but a low to moderate risk. If you join, this test may help rule out dangerous clots more quickly.
This trial tests if stable emergency room patients can be safely monitored without immediate blood tests. It may help reduce waiting times and unnecessary procedures.
This study looks at how certain parts of the bacteria that cause pneumonia (called virulence factors) and your body's natural inflammation markers are related to how well you recover. The goal is to learn more about what affects pneumonia outcomes, which could help doctors personalize treatment.
Hear when a new D-dimer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.